Orexigen Therapeutics Inc (NASDAQ:OREX)

5.01
Delayed Data
As of May 22
 +0.01 / +0.20%
Today’s Change
3.11
Today|||52-Week Range
9.37
-17.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues4.4M3.4M3.4M55.5M
 
 
 
 
 
Depreciation And Amortization443.0K313.0K94.0K139.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.0M------
 
 
General Expenses31.8M93.4M80.5M85.9M
 
 
 
 
 
Research And Development12.8M73.7M56.7M57.4M
 
 
 
 
 
Total Operating Expenses32.3M93.7M80.6M86.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.9M-90.2M-77.2M-30.5M
 
 
 
 
 
Interest Expense On Debt221.0K2.0K538.0K7.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.1M-90.1M-77.7M-37.5M
 
 
 
 
 
Net Income-28.1M-90.1M-77.7M-37.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.3M70.7M96.5M118.2M
 
 
 
 
 
Shares To Calculate EPS Diluted48.3M70.7M96.5M118.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.58-$1.27-$0.80-$0.32
 
 
 
 
 
EPS Diluted-$0.58-$1.27-$0.80-$0.32
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account